Compare MSLE & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MSLE | QTRX |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 135.3M |
| IPO Year | 2007 | 2017 |
| Metric | MSLE | QTRX |
|---|---|---|
| Price | $6.78 | $2.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $24.17 | $3.17 |
| AVG Volume (30 Days) | 45.1K | ★ 459.6K |
| Earning Date | 11-15-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $3.21 |
| Revenue Next Year | N/A | $9.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $5.44 | $2.15 |
| 52 Week High | $13.39 | $8.77 |
| Indicator | MSLE | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 44.09 |
| Support Level | $5.52 | $2.84 |
| Resistance Level | $10.58 | $3.99 |
| Average True Range (ATR) | 0.54 | 0.18 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 22.18 | 28.03 |
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.